Advertisement

More articles from Research Articles

  • Sorafenib Enhances Regional Chemotherapy in Melanoma
    Christina K. Augustine, Hiroaki Toshimitsu, Sin-Ho Jung, Patricia A. Zipfel, Jin S. Yoo, Yasunori Yoshimoto, M. Angelica Selim, James Burchette, Georgia M. Beasley, Nicole McMahon, James Padussis, Scott K. Pruitt, Francis Ali-Osman, Douglas S. Tyler
    Molecular Cancer Therapeutics Jul 2010, 9 (7) 2090-2101; DOI: 10.1158/1535-7163.MCT-10-0073
  • G1 Arrest by Ascofuranone
    Ji-Hak Jeong, Shin-Sung Kang, Kwan-Kyu Park, Hyeun-Wook Chang, Junji Magae, Young-Chae Chang
    Molecular Cancer Therapeutics Jul 2010, 9 (7) 2102-2113; DOI: 10.1158/1535-7163.MCT-09-1159
  • HPV-16 and Transcriptional Gene Silencing
    Jayanth Kumar Palanichamy, Mohit Mehndiratta, Mohita Bhagat, Pradeep Ramalingam, Brati Das, Prerna Das, Subrata Sinha, Parthaprasad Chattopadhyay
    Molecular Cancer Therapeutics Jul 2010, 9 (7) 2114-2122; DOI: 10.1158/1535-7163.MCT-09-0977
  • E1A Nanoparticles Enhance Cervical Cancer Radiosensitivity
    Liang-Fang Shen, Jia Chen, Shan Zeng, Rong-Rong Zhou, Hong Zhu, Mei-Zuo Zhong, Ruo-Jing Yao, Hong Shen
    Molecular Cancer Therapeutics Jul 2010, 9 (7) 2123-2130; DOI: 10.1158/1535-7163.MCT-09-1150
  • Internalizing Antibodies Targeting Tumor Sphere Cells
    Xiaodong Zhu, Scott Bidlingmaier, Rintaro Hashizume, C. David James, Mitchel S. Berger, Bin Liu
    Molecular Cancer Therapeutics Jul 2010, 9 (7) 2131-2141; DOI: 10.1158/1535-7163.MCT-09-1059
  • A Novel TRAIL-Based Technology for Tumor Therapy
    Dirk Spitzer, Jonathan E. McDunn, Stacey Plambeck-Suess, Peter S. Goedegebuure, Richard S. Hotchkiss, William G. Hawkins
    Molecular Cancer Therapeutics Jul 2010, 9 (7) 2142-2151; DOI: 10.1158/1535-7163.MCT-10-0225
  • Trastuzumab Targeting of Metastatic Esophageal Cancer
    Stephanie J. Gros, Nina Kurschat, Thorsten Dohrmann, Uta Reichelt, Ana-Maria Dancau, Kersten Peldschus, Gerhard Adam, Robert M. Hoffman, Jakob R. Izbicki, Jussuf T. Kaifi
    Molecular Cancer Therapeutics Jul 2010, 9 (7) 2037-2045; DOI: 10.1158/1535-7163.MCT-10-0209
  • Mcl-1 Determines the Fate of KSP-Inhibited Cells
    Brian J. Tunquist, Richard D. Woessner, Duncan H. Walker
    Molecular Cancer Therapeutics Jul 2010, 9 (7) 2046-2056; DOI: 10.1158/1535-7163.MCT-10-0033
  • PX-478 Radiosensitization in Pancreatic Cancer
    David L. Schwartz, James A. Bankson, Robert Lemos, Stephen Y. Lai, Arun K. Thittai, Yi He, Galen Hostetter, Michael J. Demeure, Daniel D. Von Hoff, Garth Powis
    Molecular Cancer Therapeutics Jul 2010, 9 (7) 2057-2067; DOI: 10.1158/1535-7163.MCT-09-0768
  • Metronomic Gemcitabine Inhibits Pancreatic Cancer
    Hop S. Tran Cao, Michael Bouvet, Sharmeela Kaushal, Alex Keleman, Eric Romney, Ginna Kim, John Fruehauf, David K. Imagawa, Robert M. Hoffman, Matthew H.G. Katz
    Molecular Cancer Therapeutics Jul 2010, 9 (7) 2068-2078; DOI: 10.1158/1535-7163.MCT-10-0201

Pages